Skip to content
healthcare.dev

tizanidine hydrochloride

NDC 0591-2790, tizanidine hydrochloride, capsule, gelatin coated, from Actavis Pharma, Inc..

Product NDC
0591-2790
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021447
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2790 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE6 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0591-2790-8600591279086150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2790-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb8b01b3-bcec-4762-9d67-0db018ef6b22
  • NADAC price for package 00591279086

    GET /v1/drugs/nadac/00591279086

Use it

Look up 0591-2790 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2790 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2790. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.